Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

5.08
BATS BZX Real-Time Price
As of 11:13am ET
 +0.04 / +0.79%
Today’s Change
4.80
Today|||52-Week Range
7.54
-24.74%
Year-to-Date
Accuray (ARAY) Receives 510(k) FDA Clearance for Radixact
9:39am / Zacks.com - Paid Partner Content
Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Jun 17 / Zacks.com - Paid Partner Content
Accuray's (ARAY) TomoTherapy System Uptake on the Rise
Jun 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.04
Today’s open5.09
Day’s range5.06 - 5.13
Volume8,368
Average volume (3 months)658,255
Market cap$407.9M
Dividend yield--
Data as of 11:13am ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-8.51%
Earnings growth (this year)--
Earnings growth (next 5 years)-259.10%
Revenue growth (last year)+2.81%
P/E ratioNM
Price/Sales1.39
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc-0.41-2.31%
NVDQNovadaq Technologies...+0.04+0.41%
IMMUImmunomedics Inc+0.02+0.92%
AXGNAxoGen Inc-0.03-0.46%
Data as of 11:13am ET, 06/29/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$379.8M
Annual profit (last year)-$40.2M
Net profit margin-10.59%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joshua H. Levine
Chief Operating Officer &
Executive Vice President
Kelly J. Londy
Corporate headquarters
Sunnyvale, California

Forecasts

Partner Offers

Search for Jobs